-
Je něco špatně v tomto záznamu ?
Silent cerebral lesions and cognitive function after pulmonary vein isolation with an irrigated gold-tip catheter: REDUCE-TE Pilot study
B. Schmidt, G. Széplaki, B. Merkely, J. Kautzner, V. van Driel, F. Bourier, M. Kuniss, A. Bulava, G. Nölker, M. Khan, T. Lewalter, N. Klein, B. Wenzel, JK. Chun, D. Shah,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem
Grantová podpora
Biotronik - International
Biotronik SE & Co - International
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 1990-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1990-02-01 do Před 1 rokem
PubMed
30848001
DOI
10.1111/jce.13902
Knihovny.cz E-zdroje
- MeSH
- akční potenciály MeSH
- asymptomatické nemoci MeSH
- časové faktory MeSH
- design vybavení MeSH
- difuzní magnetická rezonance MeSH
- fibrilace síní komplikace diagnóza patofyziologie chirurgie MeSH
- incidence MeSH
- intrakraniální embolie diagnostické zobrazování epidemiologie MeSH
- katetrizační ablace škodlivé účinky přístrojové vybavení MeSH
- kognice * MeSH
- léčebná irigace škodlivé účinky přístrojové vybavení MeSH
- lidé středního věku MeSH
- lidé MeSH
- pilotní projekty MeSH
- pooperační kognitivní dysfunkce diagnóza epidemiologie psychologie MeSH
- senioři MeSH
- srdeční frekvence MeSH
- srdeční katétry * MeSH
- testy pro posouzení mentálních funkcí a demence MeSH
- venae pulmonales patofyziologie chirurgie MeSH
- výsledek terapie MeSH
- zlato * MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Německo MeSH
INTRODUCTION: Stroke is one of the most feared complications during catheter ablation of atrial fibrillation (AF). While symptomatic thromboembolic events are rare, magnetic resonance imaging (MRI) may identify asymptomatic (ie, silent) cerebral lesions (SCLs) following pulmonary vein isolation (PVI) procedures. METHODS AND RESULTS: The REDUCE-TE Pilot was a prospective multicenter, single-arm observational study investigating the incidence of SCL in patients with symptomatic paroxysmal AF undergoing PVI with a novel gold-tip, externally irrigated ablation catheter. After ablation, cerebral diffusion-weighted MRI and a postablation follow-up were performed at 1 to 3 days after the ablation procedure. A neurocognitive test was done before and after ablation. The primary study endpoint was the occurrence of one or more new SCLs. Secondary study endpoints included neurocognitive status, procedural success rate, and periprocedural complications including symptomatic thromboembolic events. A total of 104 patients were enrolled (69% male, mean age: 61.5 ± 9.7 years, mean CHA2 DS 2 -VASc score: 1.7 ± 1.2). Postprocedural MRI examination was performed in 97 patients, and in nine of them (9.3%; 95% CI: 4.3-16.9%) a total of 11 SCLs were detected. Univariate analyses did not reveal any significant predictor for new SCLs. Nonsignificant trends were observed for low activated clotting time during ablation and for international normalized ratio value outside the range of 2 to 3 at ablation. There was no evidence of significant deterioration of neurocognitive function after PVI. In four patients, a pericardial tamponade was noted but all patients fully recovered during follow-up. CONCLUSIONS: Ablation of AF using a novel gold-tip, externally irrigated ablation catheter, resulted in SCLs in approximately one out of 10 patients without a measurable effect on neurocognitive function.
Biotronik SE and Co KG Berlin Germany
Cardioangiologisches Centrum Bethanien Frankfurt Germany
Deutsches Herzzentrum München Germany
Haga Ziekenhuis Den Haag The Netherlands
Hôpitaux Universitaires de Genève Geneva Switzerland
Katharinen Hospital Unna Germany
Kerckhoff Klinik Bad Nauheim Germany
Klinikum St Georg Leipzig Germany
Onze Lieve Vrouwe Gasthuis Amsterdam The Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025835
- 003
- CZ-PrNML
- 005
- 20201222155459.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jce.13902 $2 doi
- 035 __
- $a (PubMed)30848001
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Schmidt, Boris $u Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
- 245 10
- $a Silent cerebral lesions and cognitive function after pulmonary vein isolation with an irrigated gold-tip catheter: REDUCE-TE Pilot study / $c B. Schmidt, G. Széplaki, B. Merkely, J. Kautzner, V. van Driel, F. Bourier, M. Kuniss, A. Bulava, G. Nölker, M. Khan, T. Lewalter, N. Klein, B. Wenzel, JK. Chun, D. Shah,
- 520 9_
- $a INTRODUCTION: Stroke is one of the most feared complications during catheter ablation of atrial fibrillation (AF). While symptomatic thromboembolic events are rare, magnetic resonance imaging (MRI) may identify asymptomatic (ie, silent) cerebral lesions (SCLs) following pulmonary vein isolation (PVI) procedures. METHODS AND RESULTS: The REDUCE-TE Pilot was a prospective multicenter, single-arm observational study investigating the incidence of SCL in patients with symptomatic paroxysmal AF undergoing PVI with a novel gold-tip, externally irrigated ablation catheter. After ablation, cerebral diffusion-weighted MRI and a postablation follow-up were performed at 1 to 3 days after the ablation procedure. A neurocognitive test was done before and after ablation. The primary study endpoint was the occurrence of one or more new SCLs. Secondary study endpoints included neurocognitive status, procedural success rate, and periprocedural complications including symptomatic thromboembolic events. A total of 104 patients were enrolled (69% male, mean age: 61.5 ± 9.7 years, mean CHA2 DS 2 -VASc score: 1.7 ± 1.2). Postprocedural MRI examination was performed in 97 patients, and in nine of them (9.3%; 95% CI: 4.3-16.9%) a total of 11 SCLs were detected. Univariate analyses did not reveal any significant predictor for new SCLs. Nonsignificant trends were observed for low activated clotting time during ablation and for international normalized ratio value outside the range of 2 to 3 at ablation. There was no evidence of significant deterioration of neurocognitive function after PVI. In four patients, a pericardial tamponade was noted but all patients fully recovered during follow-up. CONCLUSIONS: Ablation of AF using a novel gold-tip, externally irrigated ablation catheter, resulted in SCLs in approximately one out of 10 patients without a measurable effect on neurocognitive function.
- 650 _2
- $a akční potenciály $7 D000200
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a asymptomatické nemoci $7 D058070
- 650 _2
- $a fibrilace síní $x komplikace $x diagnóza $x patofyziologie $x chirurgie $7 D001281
- 650 12
- $a srdeční katétry $7 D062906
- 650 _2
- $a katetrizační ablace $x škodlivé účinky $x přístrojové vybavení $7 D017115
- 650 12
- $a kognice $7 D003071
- 650 _2
- $a difuzní magnetická rezonance $7 D038524
- 650 _2
- $a design vybavení $7 D004867
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a zlato $7 D006046
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a intrakraniální embolie $x diagnostické zobrazování $x epidemiologie $7 D020766
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a testy pro posouzení mentálních funkcí a demence $7 D000073216
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a pooperační kognitivní dysfunkce $x diagnóza $x epidemiologie $x psychologie $7 D000079690
- 650 _2
- $a venae pulmonales $x patofyziologie $x chirurgie $7 D011667
- 650 _2
- $a léčebná irigace $x škodlivé účinky $x přístrojové vybavení $7 D007507
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 651 _2
- $a Německo $x epidemiologie $7 D005858
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Széplaki, Gábor $u Semmelweis University, Budapest, Hungary.
- 700 1_
- $a Merkely, Bela $u Semmelweis University, Budapest, Hungary.
- 700 1_
- $a Kautzner, Josef $u IKEM, Prague, Czech Republic.
- 700 1_
- $a van Driel, Vincent $u Haga Ziekenhuis, Den Haag, The Netherlands.
- 700 1_
- $a Bourier, Felix $u Deutsches Herzzentrum, München, Germany.
- 700 1_
- $a Kuniss, Malte $u Kerckhoff Klinik, Bad Nauheim, Germany.
- 700 1_
- $a Bulava, Alan $u Faculty of Health and Social Sciences, Ceske Budejovice Hospital, University of South Bohemia, Budejovice, Czech Republic.
- 700 1_
- $a Nölker, Georg $u Katharinen Hospital, Unna, Germany.
- 700 1_
- $a Khan, Muchtiar $u Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
- 700 1_
- $a Lewalter, Thorsten $u Peter Osypka Heart Center, Munich, Germany.
- 700 1_
- $a Klein, Norbert $u Klinikum St Georg, Leipzig, Germany.
- 700 1_
- $a Wenzel, Beate $u Biotronik SE & Co KG, Berlin, Germany.
- 700 1_
- $a Chun, Julian Kr $u Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
- 700 1_
- $a Shah, Dipen $u Hôpitaux Universitaires de Genève, Geneva, Switzerland.
- 773 0_
- $w MED00002569 $t Journal of cardiovascular electrophysiology $x 1540-8167 $g Roč. 30, č. 6 (2019), s. 877-885
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30848001 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155455 $b ABA008
- 999 __
- $a ok $b bmc $g 1599980 $s 1116521
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 30 $c 6 $d 877-885 $e 20190325 $i 1540-8167 $m Journal of cardiovascular electrophysiology $n J Cardiovasc Electrophysiol $x MED00002569
- GRA __
- $p Biotronik $2 International
- GRA __
- $p Biotronik SE & Co $2 International
- LZP __
- $a Pubmed-20201125